Menu
GeneBe

rs61758751

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_004637.6(RAB7A):c.423C>G(p.Ala141=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00422 in 1,614,168 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0044 ( 26 hom. )

Consequence

RAB7A
NM_004637.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.600
Variant links:
Genes affected
RAB7A (HGNC:9788): (RAB7A, member RAS oncogene family) RAB family members are small, RAS-related GTP-binding proteins that are important regulators of vesicular transport. Each RAB protein targets multiple proteins that act in exocytic / endocytic pathways. This gene encodes a RAB family member that regulates vesicle traffic in the late endosomes and also from late endosomes to lysosomes. This encoded protein is also involved in the cellular vacuolation of the VacA cytotoxin of Helicobacter pylori. Mutations at highly conserved amino acid residues in this gene have caused some forms of Charcot-Marie-Tooth (CMT) type 2 neuropathies. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 3-128807566-C-G is Benign according to our data. Variant chr3-128807566-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 285287.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128807566-C-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.6 with no splicing effect.
BS2
High AC in GnomAd at 388 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RAB7ANM_004637.6 linkuse as main transcriptc.423C>G p.Ala141= synonymous_variant 5/6 ENST00000265062.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RAB7AENST00000265062.8 linkuse as main transcriptc.423C>G p.Ala141= synonymous_variant 5/61 NM_004637.6 P1

Frequencies

GnomAD3 genomes
AF:
0.00255
AC:
388
AN:
152196
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000820
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00445
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00287
AC:
722
AN:
251354
Hom.:
2
AF XY:
0.00304
AC XY:
413
AN XY:
135842
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.00695
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00114
Gnomad FIN exome
AF:
0.000924
Gnomad NFE exome
AF:
0.00451
Gnomad OTH exome
AF:
0.00244
GnomAD4 exome
AF:
0.00439
AC:
6423
AN:
1461854
Hom.:
26
Cov.:
32
AF XY:
0.00430
AC XY:
3130
AN XY:
727224
show subpopulations
Gnomad4 AFR exome
AF:
0.000717
Gnomad4 AMR exome
AF:
0.00145
Gnomad4 ASJ exome
AF:
0.00620
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00126
Gnomad4 FIN exome
AF:
0.00133
Gnomad4 NFE exome
AF:
0.00515
Gnomad4 OTH exome
AF:
0.00422
GnomAD4 genome
AF:
0.00254
AC:
387
AN:
152314
Hom.:
0
Cov.:
32
AF XY:
0.00234
AC XY:
174
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.000818
Gnomad4 AMR
AF:
0.000784
Gnomad4 ASJ
AF:
0.00634
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.000847
Gnomad4 NFE
AF:
0.00445
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00283
Hom.:
0
Bravo
AF:
0.00260
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00474
EpiControl
AF:
0.00415

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 08, 2016- -
Charcot-Marie-Tooth disease type 2B Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesAug 18, 2023- -
Benign, criteria provided, single submitterclinical testingInvitaeJan 27, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 27, 2017- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2023RAB7A: BS1, BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Charcot-Marie-Tooth disease Benign:1
Benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 11, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
RAB7A-related disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesNov 15, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.28
Cadd
Benign
13
Dann
Benign
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61758751; hg19: chr3-128526409; API